EBD GmbH is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BIO-Europe 2015 BIO EBD Group
Share/Follow Us
Share this:
Follow this event:

BIO-Europe® 2016 Press Releases

News for BIO-Europe® 2016 will be available soon.

November 16, 2015BIO-Europe® 2015 in Munich sets record for attendance and partnering productivity Munich, Germany was the center of dealmaking activity in the life science industry during BIO-Europe® 2015. Held at Munich's International Congress Center from November 2–4, the event broke all previous records for attendance and partnering productivity. The event brought 3,520 executives from 1,886 companies and 55 countries, who engaged in over 19,000 one-to-one meetings t...  more ►

October 26, 2015BIO-Europe® 2015 is a virtual barometer of drug development future marketAn estimated 4,000 licensing opportunities to be on offer at event
BIO-Europe® 2015 international life science partnering conference, held in Munich, Germany, November 2–4, 2015, expects over 3,300 delegates representing investors, biotech innovators and pharmaceutical executives from the global drug development industry. "BIO-Europe is a valuable forum for us to meet a wide range of companies," said Jeremy Springhorn, PhD, Partner, Cor...  more ►

October 1, 2015Top life science industry executives will lead the BIO-Europe® 2015 programTopics address strategy shift in drug development approaches in recent years
The program of the BIO-Europe® 2015 international life science partnering conference, organized by EBD Group and held in Munich, Germany, November 2–4, 2015, is already packed with recognizable names and thought leaders from the global drug development industry. The opening plenary on Monday, November 2, takes a discerning look at the way big pharma companies are reconfig...  more ►

July 29, 2015European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium, ENATRANS, have launched the second edition of the Nanomedicine Award to honor the best international nanomedicine innovations for 2015. The goal of the Award is to promote and reward...  more ►

July 7, 2015BIO-Europe® 2015 in Munich to take place November 2–4, 2015
Event expected to bring over 3,300 life science dealmakers to Bavaria
The twenty-first annual BIO-Europe® international life science partnering conference will be held in Munich, Germany, November 2–4, 2015. Organized by EBD Group, the event is co-hosted by BioM Biotech Cluster Development, the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, and Cluster Biotechnology Bavaria. Bavaria is an ideal location because it ...  more ►

April 17, 2015Spotlight on Munich Business Facts Munich is home to a broad spectrum of high-capacity industries including life sciences; information and communication technology; automotive; aerospace; financial services; cross-industry technologies; skilled crafts; media/creative industries and corporate services. Munich is a growing city. The City of Munich has 1.46 million inhabitants (2013) and expects to grow to 1.65 ...  more ►


partnering360® Blog

February 8, 2016 Top 10 Digital Health Trends: Implications for Early to Mid-Stage Biopharma Guest post by Jay Goldman (Managing Director, Sensei Labs at Klick Health) and Michael W. Young (VP, Strategy at Klick Health) We recently had the pleasure of presenting on the Top 10 Digital Health Trends at Biotech Showcase™ 2016’s inaugural Digital Health Showcase. Our highly engaged audience... more ►

February 4, 2016 Can biology, even drug discovery, be “clouded”? It’s early but Andreessen Horowitz VC thinks so Digital health is not just a buzzword in the life science industry; it is an innovative, potentially disruptive, health paradigm that is gaining momentum. At Digital Health Showcase in January, CBT Advisors’ Steve Dickman met with Vijay Pande of Andreessen Horowitz, a renowned professor formerly... more ►

February 2, 2016 Where you build your healthcare IP is just as important as how you build it Guest post by Ben Ball, Business Development Manager, Australian Consulate-General   For most businesses, intellectual property is the foundation you build on. Transforming an idea into a product is only half the battle—the way you take that product to market may ultimately play a larger part... more ►

January 27, 2016 Why do we believe in Nordic life science? Guest post by Anna Sandström, Science Relations Director, AstraZeneca   While my high-speed train whirls its way across the broadest part of Sweden, from Gothenburg to Stockholm I am finishing my dinner, and as I lift the glass I once again start to philosophize about why some people tend to... more ►

January 22, 2016 Golden Ticket winner represents partnering opportunities with academia   We are proud to have sponsored the Circus before the Circus networking reception at the Four Seasons Hotel on January 10 during healthcare’s busiest week in San Francisco. Biotech Showcase™ 2016 investor and networking conference—the event where innovation meets money—broke records... more ►



partnering360:Insight Latest headlines from partnering360:Insight

February 9, 2016 Partnering Spotlight: Jiangsu Hengrui Medicine In September 2015, Jiangsu Hengrui Medicine made history by out-licensing global rights (not including China) to its PD-1 cancer immunotherapy. Incyte, a US oncology pharma, acquired the rights in a deal worth up to USD 795 million if Hengrui collects all the milestones, the largest amount ever paid for a single China pharma asset. more ►

January 19, 2016 Digital Health Showcase: State of the Industry Report Digital health is a young, vibrant industry with great potential. Now, after five years of buzz, it’s beginning to deliver on that potential with opportunities for drug developers, clinicians and patients, according to speakers at Digital Health Showcase, held in conjunction with Biotech Showcase™ 2016 January 13 in San Francisco. more ►

January 19, 2016 Bubble trouble? Investors advise cautious optimism Biotech still outperforms the S&P, attracts new investors and has a healthy pipeline. The fundamentals are still there. That’s why investment veterans speaking at the Biotech Showcase 2016 luncheon plenary January 13 in San Francisco remain optimistic despite advising CEOs to prepare for a downturn. more ►

January 19, 2016 Digital health and big pharma: A tale of two companies Digital health strategies have the potential to increase patient compliance and monitor and manage disease progression. For big pharma, they offer a way to improve patient experiences and gain deeper insights that may support outcomes-based pricing, according to experts from Novartis and Takeda Pharmaceuticals International, speaking at Digital Health Showcase January 13, held concurrently with Biotech Showcase™ 2016 in San Francisco. more ►

January 13, 2016 Medtech Showcase: State of the Industry 2016 Healthcare is converging, bringing together traditional therapeutics, precision medicine, combination products and companion diagnostics that require insightful approval and reimbursement policies. It also requires that entrepreneurs develop a keen understanding of what drives their potential markets, according to speakers at Medtech Showcase, held January 12 in San Francisco in concert with Biotech Showcase 2016. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use